Sonja Krösser

981 total citations
31 papers, 624 citations indexed

About

Sonja Krösser is a scholar working on Public Health, Environmental and Occupational Health, Ophthalmology and Immunology and Allergy. According to data from OpenAlex, Sonja Krösser has authored 31 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 17 papers in Ophthalmology and 11 papers in Immunology and Allergy. Recurrent topics in Sonja Krösser's work include Ocular Surface and Contact Lens (23 papers), Glaucoma and retinal disorders (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Sonja Krösser is often cited by papers focused on Ocular Surface and Contact Lens (23 papers), Glaucoma and retinal disorders (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Sonja Krösser collaborates with scholars based in United States, Germany and France. Sonja Krösser's co-authors include Philipp Steven, David Wirta, John D. Sheppard, Michael Beckert, Joseph B. Ciolino, Thomas Kaercher, Joseph Tauber, Jason L. Vittitow, George W Ousler and Andreas Johne and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Sonja Krösser

29 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sonja Krösser United States	16	452	233	208	138	119	31	624
Tadahiro Murakami Japan	11	415 0.9×	189 0.8×	211 1.0×	82 0.6×	48 0.4×	24	559
Mark L. McDermott United States	19	198 0.4×	530 2.3×	660 3.2×	40 0.3×	12 0.1×	47	928
M Göbbels Germany	8	315 0.7×	173 0.7×	170 0.8×	39 0.3×	39 0.3×	17	406
J Graham United Kingdom	12	238 0.5×	184 0.8×	207 1.0×	35 0.3×	5 0.0×	21	579
Jaap A. van Best Netherlands	16	274 0.6×	325 1.4×	409 2.0×	12 0.1×	21 0.2×	38	684
Kathleen Fillacier France	4	291 0.6×	231 1.0×	415 2.0×	7 0.1×	21 0.2×	6	518
Roberto González-Salinas Mexico	14	94 0.2×	251 1.1×	402 1.9×	9 0.1×	6 0.1×	56	601
Jieli Wu China	10	116 0.3×	56 0.2×	43 0.2×	7 0.1×	21 0.2×	25	358
Jess T. Whitson United States	21	353 0.8×	426 1.8×	866 4.2×	25 0.2×	4 0.0×	41	1.0k
Lisa Cheeks United States	13	110 0.2×	156 0.7×	240 1.2×	55 0.4×	2 0.0×	41	427

Countries citing papers authored by Sonja Krösser

Since Specialization

Citations

This map shows the geographic impact of Sonja Krösser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Krösser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Krösser more than expected).

Fields of papers citing papers by Sonja Krösser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Krösser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Krösser. The network helps show where Sonja Krösser may publish in the future.

Co-authorship network of co-authors of Sonja Krösser

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja Krösser. A scholar is included among the top collaborators of Sonja Krösser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja Krösser. Sonja Krösser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krösser, Sonja, et al.. (2025). Ocular Pharmacokinetics and Biodistribution of Perfluorohexyloctane after Topical Administration to Rabbits. Journal of Ocular Pharmacology and Therapeutics. 41(7). 370–377.

Akpek, Esen K., John D. Sheppard, & Sonja Krösser. (2025). Corneal Staining Responder Analysis. Ophthalmology. 132(12). 1335–1341.

Kaercher, Thomas, et al.. (2024). Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye disease. Graefe s Archive for Clinical and Experimental Ophthalmology. 263(4). 1051–1060. 2 indexed citations

Akpek, Esen K., et al.. (2024). Efficacy of a new water-free topical cyclosporine 0.1% solution for optimizing the ocular surface in patients with dry eye and cataract. Journal of Cataract & Refractive Surgery. 50(6). 644–650. 4 indexed citations

Harthan, Jennifer, David G. Evans, Jack V. Greiner, et al.. (2024). Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials. SHILAP Revista de lepidopterología. 4. 1452422–1452422. 3 indexed citations

Agarwal, Priyanka, et al.. (2023). Preclinical characterization of water-free cyclosporine eye drops – Factors impacting ocular penetration ex vivo and in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 188. 100–107. 5 indexed citations

Sheppard, John D., et al.. (2023). NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study. American Journal of Ophthalmology. 252. 265–274. 39 indexed citations

Akpek, Esen K., David Wirta, Joseph Tauber, et al.. (2023). Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease. JAMA Ophthalmology. 141(5). 459–459. 39 indexed citations

Schmidl, Doreen, Ahmed M. Bata, Valentin Aranha dos Santos, et al.. (2020). Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial. Journal of Ocular Pharmacology and Therapeutics. 36(3). 154–161. 35 indexed citations

10.

Wirta, David, Gail Torkildsen, John Lonsdale, et al.. (2019). A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease. Ophthalmology. 126(6). 792–800. 56 indexed citations

11.

Agarwal, Priyanka, et al.. (2019). Topical semifluorinated alkane-based azithromycin suspension for the management of ocular infections. European Journal of Pharmaceutics and Biopharmaceutics. 142. 83–91. 24 indexed citations

12.

Eberwein, Philipp, Sonja Krösser, & Philipp Steven. (2019). Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study. Ophthalmic Research. 63(1). 50–58. 7 indexed citations

13.

Agarwal, Priyanka, et al.. (2019). Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics. The Ocular Surface. 17(2). 241–249. 32 indexed citations

14.

Steven, Philipp, Albert J. Augustin, Gerd Geerling, et al.. (2017). Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease. Journal of Ocular Pharmacology and Therapeutics. 33(9). 678–685. 42 indexed citations

15.

Steven, Philipp, Dieter Scherer, Sonja Krösser, et al.. (2015). Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study. PubMed Central. 55 indexed citations

16.

Johne, Andreas, et al.. (2013). Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects. Clinical Pharmacology in Drug Development. 2(1). 79–89. 15 indexed citations

17.

Marquet, Anne, et al.. (2012). The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial. Clinical Pharmacology & Therapeutics. 92(4). 450–7. 30 indexed citations

18.

Krösser, Sonja, et al.. (2007). Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 45(5). 271–280. 6 indexed citations

19.

Krösser, Sonja, et al.. (2007). Investigation of the impact of sarizotan on the pharmacokinetics of levodopa. Biopharmaceutics & Drug Disposition. 28(7). 339–347. 9 indexed citations

20.

Krösser, Sonja, et al.. (2006). Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial. European Journal of Clinical Pharmacology. 62(4). 277–284. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact